BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20149468)

  • 1. Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies.
    Selvaraj V; Plane JM; Williams AJ; Deng W
    Trends Biotechnol; 2010 Apr; 28(4):214-23. PubMed ID: 20149468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cell fate switch: lineage reprogramming].
    Sun HY; Wang F; Cao WG
    Yi Chuan; 2012 Aug; 34(8):985-92. PubMed ID: 22917903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells for regenerative medicine.
    Hirschi KK; Li S; Roy K
    Annu Rev Biomed Eng; 2014 Jul; 16():277-94. PubMed ID: 24905879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: harmonies played by microRNAs in cell fate reprogramming.
    Moradi S; Asgari S; Baharvand H
    Stem Cells; 2014 Jan; 32(1):3-15. PubMed ID: 24155164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart regeneration using reprogramming technology.
    Ieda M
    Proc Jpn Acad Ser B Phys Biol Sci; 2013; 89(3):118-28. PubMed ID: 23474887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past, Present, and Future of Direct Cell Reprogramming.
    Ahlenius H
    Cell Reprogram; 2022 Oct; 24(5):205-211. PubMed ID: 36219713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
    Wang AYL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine.
    Asuelime GE; Shi Y
    J Mol Cell Biol; 2012 Aug; 4(4):190-6. PubMed ID: 22371436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonviral delivery for reprogramming to pluripotency and differentiation.
    Park HJ; Shin J; Kim J; Cho SW
    Arch Pharm Res; 2014 Jan; 37(1):107-19. PubMed ID: 24222505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
    Yamakawa H; Ieda M
    Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain.
    López-León M; Outeiro TF; Goya RG
    Ageing Res Rev; 2017 Nov; 40():168-181. PubMed ID: 28903069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.
    Nsair A; MacLellan WR
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):324-30. PubMed ID: 21371511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery.
    Campbell KA; Terzic A; Nelson TJ
    Regen Med; 2015; 10(6):773-83. PubMed ID: 26439809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies.
    Brouwer M; Zhou H; Nadif Kasri N
    Stem Cell Rev Rep; 2016 Feb; 12(1):54-72. PubMed ID: 26424535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.